Neurosurgeons have, for the first time, combined real-time magnetic resonance imaging (MRI) technology with novel non-invasive cellular mapping techniques to develop a new biopsy approach that increases the accuracy of diagnosis for patients with brain cancer. As many as one third of brain tumor biopsies performed in the traditional manner can result in misdiagnosis.